Targeted Therapies in Oncology provides evidence-based news and updates on the most current advances in therapeutics, biomarkers, pathways, biomarkers, molecular profiling, and diagnostic testing with its meeting coverage, columns, FDA news, and more. C
Giaccone G, Soria JC. Targeted Therapies in Oncology. Informa Healthcare USA Inc 2007; 1st Chapter: pp. 1-17.Mountzios G and Soria JCh. Targeted therapies in Oncology. Giuseppe Giaccone and Jean- Charles Soria (eds), New York, 2007....
- 《International Journal of Clinical Pharmacy》 被引量: 2发表: 2018年 The use of targeted therapies in gastrointestinal oncology In recent years, several drugs have been approved that specifically target molecular changes in tumour cells. For patients with gastrointestinal cancer, th... S Lange -...
Abnormal alterations in human epidermal growth factor receptor 2 (HER2, neu, and erbB2) are associated with the development of many tumors. It is currently a crucial treatment for multiple cancers. Advanced in molecular biology and further exploration of
Oncology: targeted therapies have opened doors to tumor control, especially when paired with appropriate diagnostics and their use in ever-evolving combinations. As drugmakers aim for smaller and more focused patient groups, setting realistic expectations on pricing and revenue potential remains ...
Targeted therapies in veterinary oncology Veterinary Ireland JournalGrant, Iain A.
Targeted therapies articles from across Nature Portfolio Atom RSS Feed A targeted therapy is one that has been developed to affect a specific target, such as an enzyme or receptor. Targeted therapies can either block or increase the function of their target in order to treat a given disease;...
In this issue of the Magazine of European Medical Oncology (MEMO), we provide a series of articles on new targeted therapies and small molecules. The challenging decision-making process for targeted therapies is discussed in the article “Tracking mutation and drug-driven alterations of oncokinase ...
HER2 targeted therapies in different cancer Breast cancer Antibodies The introduction of HER2-targeted therapy has revolutionized the landscape of breast cancer treatment. The currently approved HER2 monoclonal antibodies (mAb) for breast cancer treatment include trastuzumab and pertuzumab. Trastuzumab (Hercept...
HER2-targeted therapies are also being tested in patients with other solid tumours harbouring HER2 overexpression, and/or amplifications or other mutations of the gene encoding HER2 (ERBB2), including biliary tract, colorectal, non-small-cell lung and bladder cancers. The experience with gastric ...